kidney disease

Pharma

Sobi places $300M bet on Empaveli in partnership with Apellis

Sobi will pay partner Apellis $275 million upfront and up to $25 million in potential milestones to reduce its ex-U.S. royalty obligations on Empaveli.

Kevin Dunleavy Jul 1, 2025 11:28am

Pfizer CEO, Otsuka, Novartis-MSN—Fierce Pharma Asia

Jun 13, 2025 9:18am

David Rush and Brian Kennedy the musciains in Travere Therapeutics Play It Forward campaign sitting side by side

Travere taps Grammy-winning producer to create patient anthem

Jun 10, 2025 12:18pm

Second Novartis drug in IgAN troika crosses FDA finish line

Apr 3, 2025 10:56am

Novartis' Fabhalta nod in C3G leaves room for rival Apellis

Mar 21, 2025 10:37am

Vertex centers National Kidney Month awareness on patient story

Mar 7, 2025 9:15am